GW Pharmaceuticals Current Ratio 2013-2019 | GWPH

GW Pharmaceuticals current ratio from 2013 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
GW Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-09-30 $0.70B $0.10B 7.33
2019-06-30 $0.70B $0.08B 8.31
2019-03-31 $0.61B $0.08B 7.81
2018-12-31 $0.65B $0.07B 9.77
2018-09-30 $0.00B 0.00
2018-06-30 $0.49B $0.06B 8.67
2018-03-31 $0.54B $0.05B 11.32
2017-12-31 $0.61B $0.05B 11.44
2017-06-30 $0.41B $0.04B 10.39
2017-03-31 $0.44B $0.03B 13.46
2016-12-31 $0.49B $0.05B 9.92
2016-06-30 $0.28B $0.05B 6.09
2016-03-31 $0.32B $0.05B 6.86
2015-12-31 $0.36B $0.06B 6.62
2015-09-30 $0.39B $0.04B 9.19
2015-06-30 $0.42B $0.04B 10.44
2015-03-31 $0.24B $0.03B 7.96
2014-12-31 $0.26B $0.03B 8.53
2014-09-30 $0.29B $0.03B 10.18
2014-06-30 $0.31B $0.04B 8.67
2014-03-31 $0.18B $0.02B 7.70
2013-12-31 $0.08B $0.03B 3.35
2013-09-30 $0.08B $0.02B 3.79
2013-06-30 $0.08B $0.02B 3.61
2013-03-31 $0.05B $0.02B 2.58
2012-12-31 $0.06B $0.02B 3.05
2012-09-30 $0.06B $0.02B 3.05
2012-06-30 $0.00B 0.00
2012-03-31 $0.05B $0.02B 2.59
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.198B $0.013B
GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and neuropathic pain. It operates primarily in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc is based in Salisbury, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $150.743B 27.50
Medtronic (MDT) Ireland $150.390B 20.78
Stryker (SYK) United States $76.022B 25.56
Boston Scientific (BSX) United States $60.297B 28.46
Baxter (BAX) United States $42.111B 25.54
Essilor Luxottica (ESLOY) France $33.472B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.363B 19.05
Terumo (TRUMY) Japan $27.248B 34.00
Coloplast (CLPBY) Denmark $25.801B 39.82
Lonza Group Ag (LZAGY) Switzerland $25.334B 0.00
ResMed (RMD) United States $21.594B 39.84
Smith & Nephew SNATS (SNN) United Kingdom $19.340B 0.00
Sunny Optical Technology (SNPTF) China $18.646B 0.00
Insulet (PODD) United States $11.389B 541.85
Bio-Rad Laboratories (BIO) United States $11.046B 53.02
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
William Demant Holdings (WILYY) Denmark $7.531B 0.00
Hill-Rom Holdings (HRC) United States $7.116B 20.98
Perrigo (PRGO) Ireland $7.052B 13.15
Canopy Growth (CGC) Canada $6.483B 0.00
Haemonetics (HAE) United States $6.072B 41.03
Shandong Weigao Medical Polymer (SHWGF) China $5.743B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.839B 30.23
ICU Medical (ICUI) United States $3.808B 24.83
Neogen (NEOG) United States $3.557B 59.53
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.227B 0.00
Quidel (QDEL) United States $2.876B 27.29
Aurora Cannabis (ACB) Canada $2.658B 0.00
National Vision Holdings (EYE) United States $2.391B 53.96
Agios Pharmaceuticals (AGIO) United States $2.360B 0.00
Cardiovascular Systems (CSII) United States $1.544B 0.00
InMode (INMD) Israel $1.393B 0.00
Aphria (APHA) $1.177B 0.00
AtriCure (ATRC) United States $1.174B 0.00
VAREX IMAGING (VREX) United States $1.159B 23.21
Phibro Animal Health (PAHC) United States $0.973B 18.23
NanoString Technologies (NSTG) United States $0.941B 0.00
Lantheus Holdings (LNTH) United States $0.805B 20.11
TG Therapeutics (TGTX) United States $0.765B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.758B 29.02
LeMaitre Vascular (LMAT) United States $0.717B 40.31
Quanterix (QTRX) United States $0.696B 0.00
Omeros (OMER) United States $0.662B 0.00
PetIQ (PETQ) United States $0.660B 16.09
Cerus (CERS) United States $0.573B 0.00
Surmodics (SRDX) United States $0.551B 57.32
HEXO (HEXO) $0.530B 0.00
OraSure Technologies (OSUR) United States $0.478B 28.67
MacroGenics (MGNX) United States $0.453B 0.00
Owens & Minor (OMI) United States $0.444B 16.44
Organigram Holdings (OGI) Canada $0.409B 0.00
Meridian Bioscience (VIVO) United States $0.389B 13.37
Utah Medical Products (UTMD) United States $0.387B 28.03
BioLife Solutions (BLFS) United States $0.329B 133.92
Zynex (ZYXI) United States $0.327B 37.04
Bovie Medical (APYX) United States $0.265B 0.00
United Health Products (UEEC) United States $0.262B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.250B 0.00
Viemed Healthcare (VMD) United States $0.233B 24.52
Vapotherm (VAPO) United States $0.221B 0.00
Liberty Health Sciences (LHSIF) Canada $0.188B 0.00
Repro-Med Systems (KRMD) United States $0.186B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.176B 0.00
InfuSystems Holdings (INFU) United States $0.158B 798.00
Chimerix (CMRX) United States $0.145B 0.00
Female Health (VERU) United States $0.145B 0.00
Rockwell Medical (RMTI) United States $0.138B 0.00
Fonar (FONR) United States $0.129B 9.11
Cytosorbents (CTSO) United States $0.117B 0.00
MTech Acquisition (KERN) United States $0.116B 0.00
United-Guardian (UG) United States $0.091B 23.02
Oramed Pharmaceuticals (ORMP) United States $0.081B 0.00
Chembio Diagnostics (CEMI) United States $0.070B 0.00
Nephros (NEPH) United States $0.065B 0.00
MRI Interventions (MRIC) United States $0.059B 0.00
Surface Oncology (SURF) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.017B 0.00
GUARDION HEALTH (GHSI) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Myomo (MYO) United States $0.008B 0.00
Capricor Therapeutics (CAPR) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00